US 12,384,802 B2
Manufacturing of dimeric contrast agent
Sonia Gazzetto, Cascinette d'Ivrea (IT); Valeria Boi, Strambino (IT); Andrea Banin, Collegno (IT); and Andrea Barale, Bibiana (IT)
Assigned to BRACCO IMAGING S.P.A., Milan (IT)
Appl. No. 18/719,054
Filed by BRACCO IMAGING S.P.A., Milan (IT)
PCT Filed Dec. 13, 2022, PCT No. PCT/EP2022/085615
§ 371(c)(1), (2) Date Jun. 12, 2024,
PCT Pub. No. WO2023/110867, PCT Pub. Date Jun. 22, 2023.
Claims priority of application No. 21214327 (EP), filed on Dec. 14, 2021.
Prior Publication US 2024/0425527 A1, Dec. 26, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 403/12 (2006.01); A61K 49/10 (2006.01); C07D 257/02 (2006.01); C07F 5/00 (2006.01)
CPC C07F 5/003 (2013.01) 21 Claims
 
1. A process for the manufacturing of a dimeric complex of formula 5

OG Complex Work Unit Chemistry
comprising the following steps:
a) admixing a salt of formula 1B

OG Complex Work Unit Chemistry
wherein X is bromide, and y is 1;
with a basic aqueous solution and an organic solvent immiscible with the basic aqueous solution, to provide a heterogenous mixture comprising the salt of formula 1B, wherein the organic solvent is methyl tert-butyl ether (MTBE);
b) converting the salt of formula 1B comprised in the heterogenous mixture of step a), to provide a heterogenous mixture comprising DO3A tri-tert-butyl ester of formula 1A

OG Complex Work Unit Chemistry
c) collecting the organic solvent from the heterogenous mixture of step b), to obtain an organic solution comprising DO3A tri-tert-butyl ester 1A;
d) preparing a solution comprising a compound of formula 2

OG Complex Work Unit Chemistry
 in an organic solvent;
e) admixing the solutions of steps c) and d) to obtain a solution comprising a compound of formula 3

OG Complex Work Unit Chemistry
f) without isolating the compound from the solution of step e), removing the tert-butyl protecting groups from the compound of formula 3 to obtain a solution comprising a free ligand of formula 4

OG Complex Work Unit Chemistry
g) without isolating the free ligand of formula 4, adding gadolinium metal ions to the solution of step f) to obtain a solution comprising the dimeric complex of formula 5; and
h) isolating the dimeric complex of formula 5,
wherein the solvent in all the steps following the obtaining of the compound of formula 3 is an aqueous solvent.